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The Role of the Medical School Training on
Physician Opioid Prescribing Practices:
Evidence from Ontario, Canada
Le roˆle de la formation a` la faculte´ de me´decine a` l’e´gard des
pratiques de prescription d’opioı¨des des me´decins: donne´es
probantes d’Ontario, Canada
Claire de Oliveira, MA, PhD1,2,3,4 , Tomisin Iwajomo, MPH2,
Tara Gomes, MHSc, PhD3,4,5,6, and Paul Kurdyak, MD, MSc, PhD, FRCP(C)2,3,4,7
Abstract
Background: Recent research found that physicians who completed medical school training at top-ranked U.S. medical
schools prescribed fewer opioids than those trained at lower ranked schools, suggesting that physician training may play a role
in the opioid epidemic. We replicated this analysis to understand whether this finding holds for Ontario, Canada.
Methods:We used data on all opioid prescriptions written by Ontario physicians between 2013 and 2017 from the Narcotics
Monitoring System. Using the Corporate Provider Database and ICES Physician Database, which contain medical school of
training, we linked patients who filled opioid prescriptions with their respective prescribing physician. Available data on
Canadian medical school rankings were obtained from Maclean’s news magazine. We used regression analysis to assess the
relationship between number of opioid prescriptions and medical school ranking.
Results: Compared to the United States, average annual number of opioid prescriptions per physician was lower in Ontario
(236 vs. 78). Unlike the United States, we found little evidence that physicians trained at lower ranked medical schools
prescribed more than their top-ranked school counterparts after controlling for specialty and location of practice. However,
primary care physicians trained at non-English-speaking foreign schools prescribed the most opioids even after excluding
opioid maintenance therapy–related prescriptions.
Conclusion: The role of medical school training on opioid prescribing patterns among Ontario physicians differs from that in
the United States likely due to greater homogeneity of curricula among Canadian schools. Ensuring physicians trained abroad
receive additional pain management/addiction training may help address part of the opioid epidemic in Ontario.
Abre´ge´
Contexte : Une recherche re´cente a observe´ que les me´decins qui suivaient leur formation me´dicale dans les e´coles de
me´decine ame´ricaines les mieux cote´es prescrivaient moins d’opioı¨des que ceux forme´s dans des e´coles moins bien cote´es, ce
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qui sugge`re que la formation des me´decins peut jouer un roˆle dans l’e´pide´mie d’opioı¨des. Nous avons reproduit cette analyse
pour comprendre si ce re´sultat tient pour l’Ontario, Canada.
Me´thodes : Nous avons utilise´ les donne´es de toutes les prescriptions d’opioı¨des e´crites par des me´decins ontariens entre
2013 et 2017, tire´es du Syste`me de surveillance des stupe´fiants et des substances controˆle´es. A` l’aide de la Base de donne´es
centrale sur les fournisseurs de services de sante´ et de la Base de donne´es des me´decins de l’IRSS, qui contient la formation a`
l’e´cole de me´decine, nous avons lie´ les patients qui faisaient remplir des prescriptions d’opioı¨des a` leur me´decin prescripteur
respectif. Les donne´es disponibles sur les classements des faculte´s de me´decine canadiennes ont e´te´ obtenues du magazine
d’actualite´ Maclean’s. Nous avons utilise´ l’analyse de re´gression pour e´valuer la relation entre le nombre de prescriptions
d’opioı¨des et le classement des faculte´s de me´decine.
Re´sultats : Compare´ aux E´tats-Unis, le nombre annuel moyen de prescriptions d’opioı¨des par me´decin e´tait plus faible en
Ontario (236 contre 78). Contrairement aux E´tats-Unis, nous avons trouve´ peu de donne´es probantes indiquant que les
me´decins forme´s a` des faculte´s de me´decine moins bien cote´es prescrivaient davantage que leurs homologues des e´coles au
sommet du classement, apre`s controˆle de la spe´cialite´ et de l’emplacement de la pratique. Toutefois, les me´decins des soins de
premie`re ligne forme´s dans des e´coles e´trange`res non anglophones prescrivaient le plus d’opioı¨des, meˆme apre`s l’exclusion
des prescriptions lie´es au traitement d’entretien aux opioı¨des.
Conclusion : Le roˆle de la formation a` la faculte´ de me´decine dans les mode`les de prescription d’opioı¨des chez les me´decins
de l’Ontario diffe`re de celui des E´tats-Unis, probablement en raison de la plus grande homoge´ne´ite´ des programmes d’e´tudes
dans les e´coles canadiennes. Assigner aux me´decins forme´s a` l’e´tranger une formation additionnelle sur la gestion de la
douleur/de´pendance pourrait contribuer a` re´soudre en partie l’e´pide´mie d’opioı¨des en Ontario.
Keywords
opioids, physician prescribing, administrative data
Introduction
Opioid overdose is a leading public health issue in
North America. Over the last two decades, there has been
an increase in opioid use in Canada and in the United States;
however, this pattern has changed in recent years.1,2 In 2015,
both Canada and the United States had the highest opioid
consumption per capita worldwide.3 Furthermore, opioid-
related deaths have increased dramatically in both coun-
tries.4-6 In Ontario, more than half of all opioid-related
deaths in 2016 involved prescription drugs (dispensed or
diverted), with fentanyl being the most commonly nonpre-
scribed opioid.7 Given this, policy makers have sought ways
to address this epidemic.8
Evidence suggests that increased use of opioids may be
driven partly by physician prescribing practices. Among the
suggested key drivers behind the increased opioid use in the
last 20 years is the aggressive lobbying of physicians to
prescribe opioids liberally to manage chronic pain.9 Using
U.S. Medicare emergency department data, Barnett et al.
(2017) found that long-term opioid use was significantly
higher among patients treated by physicians with a higher
propensity to prescribe opioids.10 Other U.S. research found
that physicians who completed medical school training at top
medical schools wrote significantly fewer opioid prescrip-
tions than those trained in lower ranked schools even after
controlling for specialty and location of practice.2 The
authors concluded this was due to physician education rather
than patient selection across physicians or physician selec-
tion across medical schools. These findings suggest there
may be a role for physician education in addressing the
opioid epidemic. However, there is no evidence as to
whether this relationship holds for other jurisdictions such
as Canada. We hypothesize that, given the smaller number of
Canadian medical schools, and potentially greater homoge-
neity across curricula, the U.S. findings do not apply to
Canada. Our aim was to replicate the U.S. study using data
from Ontario, Canada’s most populous province, by exam-
ining the relationship between physician opioid prescribing
patterns and medical school training and compare our results
to those reported in the United States.
Methods
Data Sources
We accessed administrative health care data through ICES,
an independent, nonprofit research institute, which main-
tains provincial health care records (www.ices.on.ca). We
employed data on all opioid prescriptions written by physi-
cians practicing in Ontario. These data were obtained from
the Narcotics Monitoring System database that includes
information on all opioid analgesic prescriptions dispensed
from community retail pharmacies across the province and
prescribers. Patients in the Narcotics Monitoring System
who received and filled an opioid prescription were linked
to their respective prescribing physician using unique phy-
sician identifiers. We used the Corporate Provider Database
to identify all physicians actively practicing in Ontario from
2013 to 2017. These physicians were linked with the ICES
Physician Database that contains information on physician
demographics, reported specialty, postal code of practice,
and year and school of graduation. Data on annual medical
school rankings from 2013 to 2017 were obtained from
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Maclean’s,11 a Canadian news magazine, which publishes
university rankings. Rankings incorporate information on
students (e.g., success of students at winning academic
awards), faculty (e.g., number who have won major awards),
resources (e.g., amount of money available for expenses),
student support (e.g., assistance available to students), and
reputation (e.g., how ready graduates are to embark on suc-
cessful careers); information on Maclean’s ranking metho-
dology can be found elsewhere.12 In Canada, there are 17
medical schools in which 6 are located in Ontario.
Physician Cohort. We examined opioid prescribing practices
among all active physicians practicing in Ontario who grad-
uated up until 2011 (school of graduation data were not
available thereafter), with a specialty that required the
degree of MD, and who were active during the analysis
period (i.e., physicians who had a status of either
“unrestricted,” “special case license,” or “group practice
only” in the Corporate Provider Database). We excluded all
physicians with missing data on graduation year, medical
school, and specialty and location of practice and those who
retired or died during the analysis period. Our final sample
included 30,844 physicians (of 39,919 active physicians)
with an observation for each year of the analysis period for
a total of 154,220 physician-years.
We used the Statistics Canada’s Postal Code Conversion
File13 and Canada Census data to link physician postal code of
practice to the respective census division. To characterize
physician census division of practice, we obtained informa-
tion on population density (number of people per square kilo-
meters), percentage of population with a high school diploma
or less, percentage of population unemployed, percentage of
individuals in the lowest neighbourhood income quintile, per-
centage of individuals living in a rural setting, and percentage
of individuals living in Northern Ontario (i.e., North East and
North West Local Health Integration Networks).
Medical School Rankings. Based on Maclean’s ranking data,
and in line with previous research,2 we created a composite
medical school rank variable based on the average of the
medical school’s rankings across all years of available data
to deal with changes in rankings over time (see Table A1 in
the Online Appendix). These data include rankings for 15 of
the 17 medical schools in Canada (from highest to lowest
ranked, where the highest was assigned 1 and the lowest
15): McGill University, University of Toronto, University
of British Columbia, Queen’s University, University of
Alberta, McMaster University, Dalhousie University, Uni-
versity of Ottawa, University of Western Ontario, University
of Calgary, Universite´ de Montre´al, Universite´ Laval, Uni-
versity of Saskatchewan, University of Manitoba, and Uni-
versite´ de Sherbrooke (Figure A1 in the Online Appendix
depicts medical school rankings; rankings among top schools
have been quite consistent over time). There was no ranking
for Memorial University of Newfoundland or the Northern
Ontario School of Medicine; therefore, these schools were
considered separately. We grouped foreign medical schools
into three categories: United States; United Kingdom, Ire-
land, Australia, and New Zealand (UKIANZ, i.e., other
English-speaking countries); and Other. (Figure A2 in the
Online Appendix provides number of physicians by medical
school of training.)
Analysis
Descriptive analysis. We produced summary statistics of
annual prescription–related outcomes such as total number
of opioid prescriptions written in Ontario, average number of
opioid prescriptions written per physician (with and without
physician-years with no opioid prescriptions, i.e., zeroes),
and the percentage of physician-years with zero prescrip-
tions. We examined the relationship between number of
opioid prescriptions and medical school ranking. Primary
care physicians (PCPs) accounted for most opioid prescrip-
tions (80%); thus, we examined all physicians and PCPs
separately (where PCPs included three subspecialty cate-
gories—general practice, family practice, and internal med-
icine; Currie and Schnell use the term GP instead of PCP;
however, the definition is the same).
In line with previous work, we tried to understand
whether patient sorting across physicians (i.e., whether
patients were more likely to choose physicians based on their
prescribing patterns) or physician sorting across medical
schools (i.e., whether physicians chose medical schools
whose training, e.g., aligned with their approach toward
opioids) played a role in our findings.2 Given our data, we
could not ascertain whether physicians self-selected into cer-
tain medical schools. Nonetheless, we could investigate
whether physicians who trained at lower ranked medical
schools were more likely to practice in specialties and/or
locations where patient use of opioids might be greater.
Therefore, we examined the average number of opioid pre-
scriptions by medical school ranking for the top 8 opioid
prescribing medical specialties (general practice, orthopedic
surgery, general surgery, obstetrics and gynecology, plastic
surgery, emergency medicine, urology, and otolaryngology)
and hematology/oncology (a composite medical specialty
that included hematology, medical oncology, and radiation
oncology). We also produced these numbers by characteris-
tics of census division of practice.
Regression analysis.Next, we undertook regression analyses to
assess the validity of our descriptive findings, while account-
ing for relevant variables, such as physician specialty and
census division of practice, in line with Schnell and Currie
(2017). Pooling data from all years, we estimated a linear
regression model through ordinary least squares, where the
dependent variable was the number of opioid prescriptions
written by each physician by year and census division and
the independent variables included indicator variables for
each ranked school, where McGill was the reference case;
indicator variables for each unranked school (the Northern
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Ontario School of Medicine and Memorial University); indi-
cator variables for U.S. schools, United Kingdom, Ireland,
Australia, and New Zealand schools, and other foreign
schools, respectively; and indicator variables for physician
specialty, census division, and year. We estimated this equa-
tion including physician-years with and without zero opioid
prescriptions for all physicians and PCPs separately. Robust
standard errors were estimated and clustered by physician.
We also estimated the equation for each of the top 8
opioid prescribing specialties and hematology/oncology to
understand whether the relationship between prescribing and
medical school differed by specialty (thus, we dropped the
indicator variables for specialty but included indicator vari-
ables for subspecialty for PCPs to account for differences
across the three subspecialties). If medical training plays a
role, the prescribing relationship will likely be weaker
among specialties that receive subsequent training in pain
management and addiction compared to those that do not.
Finally, we examined whether opioid prescribing differed
across graduation cohorts, as more recent graduates may
have received different training on pain management and
addiction than older cohorts, by estimating the equation for
each graduation cohort: before 1982, 1982 to 1991, 1992 to
2001, and 2002 to 2011.
Sensitivity analysis. Prior research was not able to examine the
number of pills included in each prescription; this may
impact our findings as the quantity of medication dispensed
can vary considerably between prescriptions. Therefore, we
also estimated regression models using the number of
opioids dispensed as the dependent variable.
Previous work included all opioids prescribed regardless
of purpose.2 However, some opioids (methadone and bupre-
norphine/naloxone) are typically prescribed to treat opioid
dependence and thus have a different purpose than those
prescribed to treat pain. Furthermore, given the nature of
their dispensing (typically daily dispensing), their inclusion
could affect our primary outcome.14 Thus, we conducted a
sensitivity analysis excluding all opioid maintenance therapy
(OMT)–related prescriptions.
Results
Descriptive Analysis
From 2013 to 2017, there was an overall decrease in the
number of opioid prescriptions in Ontario (Table 1). Physi-
cians accounted for most opioid prescriptions (87%). The
average annual number of opioid prescriptions per physician
across all years was 77.79 (standard deviation [SD] ¼
138.31) including physician-years with no opioid prescrip-
tions (i.e., zeroes) and 103.58 (SD ¼ 151.01) excluding
physician-years with no opioid prescriptions. These numbers
were higher for PCPs (124.67, SD ¼ 164.85 and 140.06, SD
¼ 168.45, respectively). Among physicians excluded from
the analysis (n ¼ 9,075, 22.7% of all active physicians in the
Corporate Provider Database between 2012 and 2017 inclu-
sive), most were missing data on medical school of training
(99.6%); many were also missing data on specialty (63%).
Just under half (47%) did not prescribe at any point during
the analysis period. The average annual number of prescrip-
tions per physician among excluded physicians was 20.45
and 52.50 with and without physician-years with no opioid
prescriptions, respectively (results not shown).
We found a negative relationship between medical school
ranking and average number of opioid prescriptions; in other
words, physicians from higher ranked schools (where higher
ranked schools were assigned a lower number) were more
likely to write opioid prescriptions (Figure 1A; Table A2 in
the Online Appendix). For example, physicians trained at
Universite´ de Sherbrooke prescribed less than those trained
at the University of Toronto (39.08, SD ¼ 68.81 vs. 82.96,
SD ¼ 142.35, respectively). Furthermore, physicians trained
at the Northern Ontario School of Medicine prescribed more
(121.74, SD ¼ 85.91) than those trained at both ranked and
unranked schools. Findings were similar for PCPs only,
except PCPs trained at the University of Western Ontario
(137.05, SD ¼ 171.28), the University of Manitoba (141.31,
SD ¼ 230.41), and other foreign schools (153.29, SD ¼
192.53), who prescribed more opioids than other PCPs
(Figure 1B; Table A3 in the Online Appendix).
Results were generally similar when we excluded
physician-years with no opioid prescriptions. Again, on
average, physicians from higher ranked schools wrote more
opioid prescriptions (Online Appendix Table A2). In partic-
ular, physicians trained at the University of Western Ontario
had an average number of prescriptions (122.37, SD ¼
162.37) close to the Northern Ontario School of Medicine
value (125.83, SD ¼ 83.34). Findings differed slightly when
we examined PCPs only (Online Appendix Table A3). While
the negative relationship between medical school rank and
opioid prescriptions held, PCPs trained at the University of
Manitoba (160.12, SD¼ 239.05) and the University of West-
ern Ontario (153.17, SD ¼ 174.14) were identified as the top
prescribers among ranked schools (Online Appendix Table
A3). However, PCPs trained at other foreign schools
(166.43) were the top prescribers among all physicians.
We also examined the number of opioid prescriptions by
specialty and location of practice (Table 2). General practice
was by far the top opioid prescribing specialty followed by
orthopedic surgery, general surgery, obstetrics and gynecol-
ogy, plastic surgery, emergency medicine, urology, and oto-
laryngology. Combined, these specialties accounted for 82%
of all opioid prescriptions (the top 8 specialties in the United
States, which accounted for 84% of all opioid prescriptions,
were general practice, orthopedic surgery, emergency med-
icine, pain medicine, physical medicine and rehabilitation,
obstetrics and gynecology, anesthesiology, and general sur-
gery; see Online Appendix Table A4 for average number of
opioid prescriptions for the top 20 specialties). Typically,
physicians trained at top ranked Canadian schools tended
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Table 1. Summary Statistics for Annual Opioid Prescription Measures.
2013 2014 2015 2016 2017 All
Total number of all opioid prescriptionsa 2,743,809 2,862,487 2,799,863 2,754,514 2,591,261 13,751,934
All physicians
Number of physicians 30,844 30,844 30,844 30,844 30,844 30,844
Number of prescribing physicians 24,440 24,085 23,294 22,512 21,481 —
Number of physician-years — — — — — 154,220
Number of opioid prescriptions 2,543,112 2,611,391 2,449,569 2,309,765 2,082,376 11,996,213
Percentage of total prescribed 92.69 91.23 87.49 83.85 80.36 87.23
Average opioid prescriptions per year including zeroes (std. deviation) 82.45 (139.55) 84.66 (150.57) 79.42 (137.84) 74.89 (134.87) 67.51 (127.02) 77.79 (138.31)
Average opioid prescriptions per year excluding zeroes (std. deviation) 104.05 (149.43) 108.42 (162.66) 105.16 (149.83) 102.6 (148.59) 96.94 (142.53) 103.58 (151.01)
Zeroes (%) 20.76 21.91 24.48 27.01 30.36 —
Primary care physicians
Number of physicians 15,166 15,166 15,166 15,166 15,166 15,166
Number of prescribing physicians 14,017 13,882 13,574 13,234 12,794 —
Number of physician-years — — — — — 75,830
Number of opioid prescriptions 2,005,360 2,070,284 1,933,355 1,813,976 1,631,074 9,454,049
Percentage of total prescribed 73.09 72.32 69.05 65.85 62.95 68.75
Average opioid prescriptions per year including zeroes (std. deviation) 132.22 (164.98) 136.51 (180.82) 127.48 (163.16) 119.61 (160.32) 107.55 (152.07) 124.67 (164.85)
Average opioid prescriptions per year excluding zeroes (std. deviation) 143.06 (167.03) 149.13 (183.95) 142.43 (166.18) 137.06 (164.50) 127.49 (157.70) 140.06 (168.45)
Zeroes (%) 7.58 8.47 10.50 12.74 15.64 —
Note. Standard deviations are displayed in parentheses and are clustered by physician.
aObtained from the Narcotics Monitoring System and includes all opioid prescriptions regardless of prescriber.
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to practice in more densely populated, urban areas located in
southern Ontario.
Regression Analysis
After controlling for physician specialty and location of
practice, the negative relationship between opioid prescrip-
tions and medical school ranking remained (Figure 2A);
however, most school rank coefficients were not statisti-
cally significant (see Table A5 in the Online Appendix for
coefficients). Compared to McGill University, physicians
trained at the University of Toronto (11.81, P value <
0.001), the University of Western Ontario (14.48, P value
< 0.001), and other foreign schools (17.16, P value < 0.001)
prescribed slightly more opioids, while those trained at the
Universite´ de Montre´al (13.61, P value ¼ 0.04) and the
University of Saskatchewan (12.49, P value ¼ 0.03) pre-
scribed slightly less.
We found similar results for PCPs only, albeit a less steep
gradient. Few coefficients were statistically significant;
however, those for the University of Manitoba (31.04,
P value ¼ 0.02) and other foreign schools (40.73, P value
< 0.001) were much higher compared to McGill University
(although smaller in value—16.97, P value < 0.001—the
coefficient for the University of Toronto was also statisti-
cally significant; Figure 2B; see Table A6 in the Online
Appendix for full list of coefficients). When we excluded
physician-years with no opioid prescriptions, few coeffi-
cients were statistically significant, the largest of which were
for other foreign schools (17.59, P value < 0.001), the Uni-
versity of Western Ontario (14.31, P value < 0.001), and the
University of Toronto (12.24, P value < 0.001). We found
similar results when we restricted our analysis to PCPs only;
the largest coefficients were for other foreign schools (39.16,
P value < 0.001), the University of Manitoba (33.07, P value
¼ 0.02), and the University of Toronto (16.85, P value ¼
0.02; see Tables A7 and A8 in the Online Appendix for full
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Figure 1. Average number of opioid prescriptions by medical school rank. (A) All physicians. (B) Primary care physicians. See Tables A2 and
A3 in the Online Appendix for values for all physicians and primary care physicians, respectively.
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Table 2. Opioid Prescriptions among Physicians in Ontario by Specialty and Location of Practice Based On Medical School of Graduation.
Full Sample
Ranked
McGill UofT UBC Queen’s Alberta MAC DAL Ottawa Western Calgary
Number of Physicians 30,844 1,380 6,976 388 1,987 453 2,668 725 2,235 3,060 429
Specialties (top 8)
General practice 14,609 496 3,420 177 901 182 1,434 329 1,155 1,559 177
Orthopedic surgery 592 23 150 12 48 7 42 17 44 68 15
General surgery 734 38 162 7 65 17 51 14 45 99 8
Obstetrics and gynecology 825 32 168 10 59 7 82 14 47 114 9
Plastic surgery 232 11 70 5 22 5 18 a 11 43 10
Emergency medicine 319 24 40 5 49 6 27 12 30 43 9
Urology 287 18 82 a 34 a 11 12 21 30 8
Otolaryngology 276 12 92 0 24 5 15 8 17 35 a
Census division of practice
Population density (people/km2) 1,465.8 1,706.0 2,179.0 1,637.3 969.0 1,552.8 1,193.9 1,107.5 805.1 984.0 1,431.7
Percentage high school or less 44.4 43.1 43.7 43.8 44.7 43.9 45.5 44.1 42.9 46.0 44.2
Percentage unemployed 8.4 8.3 8.6 8.4 8.2 8.4 8.3 8.3 7.9 8.3 8.5
Percentage low-income quintile 22.1 23.0 23.7 23.1 21.8 22.7 22.0 21.6 20.5 21.0 23.2
Percentage rural 8.1 7.3 5.4 8.6 11.7 9.1 8.7 8.7 10.9 11.3 9.3
Percentage Northern Ontariob 5.7 5.0 3.8 7.5 6.0 7.3 7.1 6.6 9.5 4.8 9.3
Ranked Unranked Foreign
Full Sample U. Mon. Laval U. Sask. U. Man U. Sher. MUN NOSM US UKIANZ Other
Number of Physicians 30,844 234 124 262 647 152 445 80 391 1,788 6,420
Specialties (top 8)
General practice 14,609 106 42 94 307 52 180 79 128 804 2,987
Orthopedic surgery 592 4 a 7 14 17 0 6 33 80
General surgery 734 7 a 5 9 5 9 0 5 43 142
Obstetrics and gynecology 825 9 a a 11 10 12 0 10 38 187
Plastic surgery 232 a a a a a a 0 a 8 12
Emergency medicine 319 a a a a a 10 0 18 6 26
Urology 287 a a a 5 a a 0 a 12 39
Otolaryngology 276 a a a a 7 5 0 a 17 26
Census division of practice
Population density (people/km2) 1,465.8 704.8 1,019.6 1,219.3 1,589.9 858.1 927.5 86.2 2,126.5 1,433.7 1,463.3
Percentage high school or less 44.4 44.0 42.2 44.1 44.8 42.4 44.9 49.1 44.3 44.9 44.5
Percentage unemployed 8.4 7.7 7.9 8.4 8.6 7.6 8.2 8.6 8.7 8.5 8.5
Percentage low-income quintile 22.1 20.2 21.4 22.3 23.1 19.6 21.2 23.2 24.7 22.4 21.2
Percentage rural 8.1 13.7 8.7 7.4 12.0 9.6 10.9 32.6 6.4 8.9 5.7
Percentage Northern Ontarioa 5.7 10.7 8.9 9.2 14.2 5.3 6.5 70.0 3.6 6.7 3.8
Note. UofT¼ University of Toronto; UBC¼ University of British Columbia; MAC¼McMaster University; DAL¼Dalhousie University; U. Mon.¼ Universite´ de Montre´al; U. Sask.¼ University of Saskatchewan; U. Man.
¼ University of Manitoba; U. Sher. ¼ Universite´ de Sherbrooke; NOSM ¼ Northern Ontario School of Medicine; UKIANZ ¼ United Kingdom, Ireland, Australia, and New Zealand; MUN ¼ Memorial University.
aSuppressed due to cell count less than 5.
b Includes North West and North East Local Health Integration Networks.
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list of coefficients). We also estimated regressions by speci-
alty and graduation cohort but found no gradient in either
case; few coefficients were statistically significant (results
are available upon request).
Sensitivity Analysis
We found similar results using number of opioids dispensed
as the outcome. We found a weak negative relationship and
few statistically significant coefficients in the adjusted anal-
ysis. Findings were qualitatively the same for PCPs only and
excluding physician-years with no opioid prescriptions and
by specialty and graduation cohort (results are available
upon request). Moreover, our main results did not change
when we excluded all OMT-related prescriptions. The larg-
est coefficients for the “all physicians” model were for other
foreign schools (21.01, P value < 0.001), followed by the
University of Western Ontario (15.90, P value < 0.001), and
the University of Toronto (12.95, P value < 0.001) including
zeroes; this was largely the case for the “PCPs only” model
(other foreign schools, 50.65, P value < 0.001; University of
Toronto, 21.48, P value < 0.001; University of Western
Ontario, 18.83, P value < 0.001). When we excluded
physician-years with no opioid prescriptions, the largest
coefficients for the “all physicians” model were for other
foreign schools (22.98, P value < 0.001), the University of
Western Ontario (16.82, P value < 0.001), and the University
of Toronto (14.71, P value < 0.001); this was also the case
for the “PCPs only” model (other foreign schools, 48.69, P
value < 0.001; the University of Toronto, 22.47, P value <
0.001; and the University of Western Ontario, 18.93, P value
< 0.001; see Tables A9 to A12 in the Online Appendix for
full list of coefficients).
Discussion
Many developed countries are currently facing an opioid
epidemic. It has been hypothesized that medical schools
may have different approaches to pain management and
addiction training, which may influence appropriate opioid
prescribing among their trainees. This analysis sought to
understand whether physician training played a role within
this context in Ontario as found in the United States. The
results suggest the role of medical school training on opioid
prescribing among physicians practicing in Ontario is
weaker than in the United States likely due to greater homo-
geneity of curricula among Canadian schools. We found a
weak negative relationship between annual opioid prescrip-
tions and medical school rank, where higher ranked schools
prescribed more opioids. This finding held when we strati-
fied the analysis by specialty and graduation cohort and
when we examined the number of opioids dispensed and
excluded OMT-related prescriptions. Nonetheless, we
found some outliers—physicians and PCPs trained at
non-English-speaking foreign schools and PCPs trained at
the University of Manitoba tended to prescribe slightly
more opioids. This was also the case when we considered
non-OMT prescriptions only, with the exception of the
University of Manitoba.
Schnell and Currie (2018) found a positive relationship
between the number of opioids prescribed and medical
school rank in the United States, where physicians trained
at top medical schools, such as Harvard, prescribed less than
those trained at lower ranked schools.2 While Harvard-
trained physicians wrote an average of 95 opioid prescrip-
tions per year (including zeroes), physicians from the lowest
ranked U.S. medical schools wrote over 3 times more (299).
Moreover, the authors found that foreign doctors wrote
fewer opioid prescriptions than U.S.-trained physicians
(albeit with differences by world region), while physicians
from unranked U.S. schools were more similar to physicians
from the lowest ranked schools. Our results differ from
theirs. First, we found a weak negative relationship between
opioid prescriptions and medical school rank even after con-
trolling for specialty and location of practice. This may be
due, in part, to there being fewer medical schools in Canada
(17 vs. 147 in the United States) and less heterogeneity
among medical school curricula. Second, the average num-
ber of opioid prescriptions written by Ontario physicians was
similar to (or lower than) that of top-ranked U.S. medical
schools. Third, physicians trained at non-English-speaking
foreign schools prescribed more opioids than those trained at
Canadian- or English-speaking foreign schools. This high-
lights the need to ensure physicians trained abroad undergo
additional training around pain management and addiction.
Also, worth noting, Ontario physicians trained at Que´bec
medical schools were among the lowest opioid prescribers.
Other work has found that Que´bec is one of the provinces
with the lowest rates of opioid use.15 Thus, there is likely a
different culture toward opioid prescribing in Que´bec, which
may be worth exploring further. Residency training, fellow-
ships, and continuing medical education should also be con-
sidered as they are likely to play a larger role than initial
medical training (although addiction fellowship are rela-
tively new). Unfortunately, this information was not avail-
able. In an effort to address this, we examined whether
physicians trained at lower ranked medical schools were
systematically more likely to practice in specialties where
patient need for opioids might be higher. We did not find this
to be the case. The potential influence of pharmaceutical
firms on medical school training pain and prescription cur-
riculum may have also played a role, but again, our analysis
was limited by the existing data.
There have been recent efforts on behalf of Canadian
medical schools and physician training programs to improve
training content in pain management, opioid prescribing, and
addiction/substance use disorders for early career practi-
tioners and to provide continuing education to all practicing
physicians16; this may explain the decline in opioid prescrip-
tions in recent years. In November 2016, Health Canada and
the then Federal Minister of Health, Dr Jane Philpott, held
the “Summit on Problematic Opioid Use,” which included
8 The Canadian Journal of Psychiatry
the Association of Faculties of Medicine of Canada. Since
then, the Association of Faculties of Medicine of Canada,
which includes all 17 faculties of medicine, has committed
to improving foundational core competencies in medical
education around opioid prescribing and pain management.
Furthermore, in 2017, guidelines were developed to inform
opioid prescribing for adults with chronic noncancer pain.17
In Ontario, the Narcotics Monitoring System was introduced
in May 2012 to collect and monitor data on all narcotics
dispensed.18 The introduction of a fentanyl patch-for-patch
program,19 which requires patients prescribed fentanyl
return used patches to pharmacies before receiving more
patches, and the delisting of high-strength opioids from the
Ontario formulary (except for palliative patients)20 have also
helped curb opioid prescribing.
To our knowledge, this is the first study to examine this
issue outside the United States and thus contributes to the
emerging literature around policies/interventions to address
the opioid epidemic. We used a population-based sample of
all physicians practicing in Ontario and examined all
opioids prescribed, regardless of form, strength, and/or
duration. Furthermore, we examined the number of opioids
dispensed, which was not available in previous work.2 Our
work has some limitations. We were unable to examine
recent graduates (i.e., those who qualified since 2011), and
many physicians had missing data on medical school of
training. Furthermore, among excluded physicians, the
average number of prescriptions was lower than that of
included physicians. Thus, there may be some sample selec-
tion bias, which we did not control for; however, this would
have been more problematic had we found an effect. Data
on medical school rankings were only available for more
recent years; furthermore, despite research suggesting that
the general procedure used by Maclean’s is sound, these
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Figure 2. Estimated mean difference (relative to McGill University) in the number of opioid prescriptions by medical school, controlling for
specialty and census division of practice. (A) All physicians. (B) Primary care physicians. McGill University is the reference case. See Tables A5
and A6 in the Online Appendix for values for all physicians and primary care physicians, respectively.
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rankings are subject to criticism.21 We were only able to
observe where each physician completed their medical
school training and not where they obtained specialty train-
ing, which limited our analysis. We were not able to adjust
for physician volume, clinical need of patients, or in-
hospital opioid administration; the inclusion of these vari-
ables may have reduced model coefficients. Moreover, we
did not control for duration of prescriptions; however, the
proportion of short-term prescriptions (5 days or less) did
not differ much among schools. We examined Ontario data
that only include 36% of all physicians in practicing in
Canada.22 Results may have differed had we used data for
the entire country. Finally, we did not examine other health
providers who prescribe opioids such as dentists, nurses/
nurse practitioners, midwives, and chiropodists. Although
physicians make up most prescribers, dental prescribers in
Ontario are responsible for about 20% to 25% of opioid
prescriptions (although these are typically of short duration
and low dose).23
In sum, our results suggest that the role of medical school
training on opioid prescribing patterns among physicians in
Ontario is not as strong as in the United States. Moreover, the
average number of opioids prescribed by Ontario physicians
is similar to that of top-ranked U.S. medical schools. None-
theless, ensuring that physicians trained abroad receive addi-
tional pain management and addiction training may help
address part of the current opioid epidemic in Ontario and
potentially elsewhere in Canada. Future work should seek to
explore prescribing patterns among other health profession-
als and replicate this analysis in other jurisdictions where
opioid use is also problematic, such as Alberta24 and Aus-
tralia,25 for example.
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